✦ LIBER ✦

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study

✍ Scribed by Lee, Mary R.; Wehring, Heidi J.; McMahon, Robert P.; Linthicum, Jared; Cascella, Nicola; Liu, Fang; Bellack, Alan; Buchanan, Robert W.; Strauss, Gregory P.; Contoreggi, Carlo; Kelly, Deanna L.

Book ID: 120509942
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 145
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2013.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster #220 INTRANASAL OXYTOCIN EFFECTS

Poster #220 INTRANASAL OXYTOCIN EFFECTS ON SOCIAL ANXIETY AND DEPRESSION IN SCHIZOPHRENIA: RESULTS FROM A DOUBLE BLIND PLACEBO CONTROLLED TRIAL

✍ Wehring, Heidi J.; Lee, Mary R.; McMahon, Robert P.; Bellack, Alan; Linthicum, J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Effects of Polysaccharide Derived from B

Effects of Polysaccharide Derived from Black Currant on Relieving Clinical Symptoms of Japanese Cedar Pollinosis: A Randomized Double-Blind, Placebo-Controlled Trial

✍ DEJIMA, Kenji; OHSHIMA, Akihiro; YANAI, Takaaki; YAMAMOTO, Reiko; TAKATA, Ryoji; 📂 Article 📅 2007 🏛 Japan Science and Technology Information Aggregato 🌐 English ⚖ 86 KB

Diabetes and schizophrenia – effect of d

Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia

✍ S. Saddichha; N. Manjunatha; S. Ameen; S. Akhtar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

The cyclooxygenase-2 inhibitor celecoxib

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

✍ Müller, N; Schwarz, M J; Dehning, S; Douhe, A; Cerovecki, A; Goldstein-Müller, B 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of

The effect of adjunctive armodafinil on

The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial

✍ William V. Bobo; Neil D. Woodward; Min Young Sim; Karuna Jayathilake; Herbert Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB